Core Insights - Acadia Healthcare is a leading provider in the behavioral healthcare sector, offering a range of services including psychiatric and addiction treatment [1] - The company is facing challenges related to governance and performance, as highlighted by a major shareholder's call for a strategic review [3] Stock Performance - On October 3, 2025, Raymond James upgraded Acadia Healthcare to "Outperform" with a new price target of $30, up from $26, indicating a positive outlook for the stock [2][5] - ACHC's stock price increased by 8.43%, or $2.07, reflecting strong investor interest, with a trading range of $24.57 to $26.72 for the day [4][5] - Over the past year, ACHC has experienced significant volatility, with a high of $60.52 and a low of $17.13 [4] Market Position - Acadia Healthcare's market capitalization is approximately $2.46 billion, indicating its substantial presence in the market [4] - The trading volume for ACHC today was 3,511,931 shares on the NASDAQ exchange, demonstrating active investor engagement [4]